EMA advises continued use of medicines for hypertension, heart or kidney disease during COVID-19 pandemic
EMA is aware of recent media reports and publications[1] which question whether some medicines, for instance angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs, or sartan medicines), could worsen coronavirus disease (COVID-19). ACE inhibitors and ARBs are most commonly used for treating patients with high blood pressure, heart failure or kidney disease. It […]